The University of Chicago Header Logo

Connection

Jonathan Rich to Heart Failure

Back to Details
This is a "connection" page, showing publications Jonathan Rich has written about Heart Failure.
Jonathan Rich
Connection Strength
4.989
Heart Failure
  1. Epidemiology of Heart Failure and the Discovery of the Cardioprotective Effects of SGLT2 Inhibitors. JACC Heart Fail. 2024 Jun; 12(6S):S1-S3.
    View in: PubMed
    Score: 0.413
  2. Hyponatremia Is a Powerful Predictor of Poor Prognosis in Left Ventricular Assist Device Patients. ASAIO J. 2022 12 01; 68(12):1475-1482.
    View in: PubMed
    Score: 0.372
  3. Risk of Renal Dysfunction Following Heart Transplantation in Patients Bridged with a Left Ventricular Assist Device. ASAIO J. 2022 05 01; 68(5):646-653.
    View in: PubMed
    Score: 0.340
  4. Obesity and Outcomes Following Cardiogenic Shock Requiring Acute Mechanical Circulatory Support. Circ Heart Fail. 2021 03; 14(3):e007937.
    View in: PubMed
    Score: 0.330
  5. The Inherent Fallacy of Predicting RV Failure Following Left Ventricular Assist Device Implantation. J Card Fail. 2019 08; 25(8):629-630.
    View in: PubMed
    Score: 0.293
  6. Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2018 10 16; 7(20):e009594.
    View in: PubMed
    Score: 0.279
  7. HVAD Flow Waveform Morphologies: Theoretical Foundation and Implications for Clinical Practice. ASAIO J. 2017 Sep-Oct; 63(5):526-535.
    View in: PubMed
    Score: 0.258
  8. The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. J Heart Lung Transplant. 2017 01; 36(1):50-58.
    View in: PubMed
    Score: 0.241
  9. Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance. Cardiovasc Ther. 2015 Apr; 33(2):42-9.
    View in: PubMed
    Score: 0.218
  10. Right ventricular failure in patients with left ventricular assist devices. Cardiol Clin. 2012 May; 30(2):291-302.
    View in: PubMed
    Score: 0.179
  11. Faces of right ventricular failure. Cardiol Clin. 2012 May; 30(2):xi.
    View in: PubMed
    Score: 0.179
  12. Association of Novel Ventricular Assist Device Self-report Measures With Overall Health-Related Quality of Life. J Cardiovasc Nurs. 2025 Jul-Aug 01; 40(4):345-355.
    View in: PubMed
    Score: 0.105
  13. Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease. JACC Heart Fail. 2024 Aug; 12(8):1328-1342.
    View in: PubMed
    Score: 0.104
  14. Summary and Panel Discussion. JACC Heart Fail. 2024 Jun; 12(6S):S10-S11.
    View in: PubMed
    Score: 0.103
  15. Efficient measurement of multiple ventricular assist device patient-reported outcomes: Creation of a 20-item profile from the MCS A-QOL study. J Heart Lung Transplant. 2024 Aug; 43(8):1308-1317.
    View in: PubMed
    Score: 0.102
  16. Novel measures to assess ventricular assist device patient-reported outcomes: Findings from the MCS A-QOL study. J Heart Lung Transplant. 2024 01; 43(1):36-50.
    View in: PubMed
    Score: 0.098
  17. Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support. J Thorac Cardiovasc Surg. 2022 10; 164(4):1120-1137.e2.
    View in: PubMed
    Score: 0.089
  18. Time Spent Engaging in Health Care Among Patients With Left Ventricular Assist Devices. JACC Heart Fail. 2022 05; 10(5):321-332.
    View in: PubMed
    Score: 0.089
  19. A Power Tracking Algorithm for Early Detection of Centrifugal Flow Pump Thrombosis. ASAIO J. 2021 09 01; 67(9):1018-1025.
    View in: PubMed
    Score: 0.085
  20. Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial. JACC Heart Fail. 2021 05; 9(5):360-370.
    View in: PubMed
    Score: 0.083
  21. Cardiac transplantation outcomes in patients with amyloid cardiomyopathy. Am Heart J. 2021 06; 236:13-21.
    View in: PubMed
    Score: 0.082
  22. Association of cigarette smoking and adverse events in left ventricular assist device patients. Int J Artif Organs. 2021 Mar; 44(3):181-187.
    View in: PubMed
    Score: 0.079
  23. Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes. Circ Heart Fail. 2019 04; 12(4):e006067.
    View in: PubMed
    Score: 0.072
  24. Bridge to Transplantation With Long-Term Mechanical Assist Devices in Adults With Transposition of the Great Arteries. Artif Organs. 2019 Jan; 43(1):90-96.
    View in: PubMed
    Score: 0.070
  25. Pre-Ventricular Assist Device Palliative Care Consultation: A Qualitative Analysis. J Pain Symptom Manage. 2019 01; 57(1):100-107.
    View in: PubMed
    Score: 0.070
  26. Cardiac Structure-Function MRI in Patients After Heart Transplantation. J Magn Reson Imaging. 2019 03; 49(3):678-687.
    View in: PubMed
    Score: 0.069
  27. Controversies and Challenges of Ventricular Assist Device Therapy. Am J Cardiol. 2018 05 15; 121(10):1219-1224.
    View in: PubMed
    Score: 0.067
  28. Long-Term Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist Device. Ann Thorac Surg. 2018 03; 105(3):696-701.
    View in: PubMed
    Score: 0.066
  29. Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project. JACC Heart Fail. 2016 12; 4(12):911-919.
    View in: PubMed
    Score: 0.061
  30. Outpatient Use of Focused Cardiac Ultrasound to Assess the Inferior Vena Cava in Patients With Heart Failure. Am J Cardiol. 2015 Oct 15; 116(8):1224-8.
    View in: PubMed
    Score: 0.056
  31. Echocardiography and Continuous-Flow Left Ventricular Assist Devices: Evidence and Limitations. JACC Heart Fail. 2015 Jul; 3(7):554-564.
    View in: PubMed
    Score: 0.055
  32. Sharing the care of mechanical circulatory support: collaborative efforts of patients/caregivers, shared-care sites, and left ventricular assist device implanting centers. Circ Heart Fail. 2015 May; 8(3):629-35.
    View in: PubMed
    Score: 0.055
  33. Clinical diagnosis of pulmonary hypertension. Circulation. 2014 Nov 11; 130(20):1820-30.
    View in: PubMed
    Score: 0.053
  34. Acute kidney injury and mortality following ventricular assist device implantation. Am J Nephrol. 2014; 39(3):195-203.
    View in: PubMed
    Score: 0.051
  35. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014 Mar 01; 7(2):288-99.
    View in: PubMed
    Score: 0.050
  36. The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2013 Dec; 10(4):401-10.
    View in: PubMed
    Score: 0.050
  37. Modified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survival. ASAIO J. 2014 Nov-Dec; 60(6):613-6.
    View in: PubMed
    Score: 0.013
  38. Treatment of left ventricular assist device thrombosis with extended catheter-directed intraventricular thrombolytic therapy. Circ Heart Fail. 2013 May; 6(3):e27-9.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.